WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004035060) BISPHOSPHONATES FOR THE TREATMENT OF ANTHEROSCLEOROSIS AND DEVICES COMPRISING THEM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/035060    International Application No.:    PCT/EP2003/011379
Publication Date: 29.04.2004 International Filing Date: 14.10.2003
Chapter 2 Demand Filed:    26.04.2004    
IPC:
A61K 31/663 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichstrasse 35, CH-4056 Basel (CH) (AE, AG, AL, AM, AU, AZ, BA, BB, BE, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, FR, GB, GD, GE, GH, GR, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MC, MD, MK, MN, MX, NI, NL, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SE, SG, SI, SK, SY, TJ, TM, TN, TR, TT, UA, UZ, VC, VN, YU, ZA, ZW only).
NOVARTIS PHARMA GMBH [AT/AT]; Brunner Strasse 59, A-1230 Vienna (AT) (AT only).
PRESCOTT, Margaret, Forney [US/US]; (US) (For US Only)
Inventors: PRESCOTT, Margaret, Forney; (US)
Agent: GRUBB, Philip; Novartis AG, Corporate Intellectual Property, CH-4002 Basel (CH)
Priority Data:
60/418,554 15.10.2002 US
60/428,621 22.11.2002 US
Title (EN) BISPHOSPHONATES FOR THE TREATMENT OF ANTHEROSCLEOROSIS AND DEVICES COMPRISING THEM
(FR) BISPHOSPHONATES UTILISES DANS LE TRAITEMENT DE L'ATHEROSCLEROSE ET DISPOSITIFS LES CONTENANT
Abstract: front page image
(EN)A method for the treatment of atherosclerosis, in particular atherosclerotic/valve calcification and plaque rupture/stroke, in a patient in need of such treatment, e.g. a patient with aterial or valve calcification, which comprises administering an effective amount of a bisphosphonate, e.g. zoledronic acid or salts or hydrates thereof, to the patient. Especially the invention relates to the local administration the bisphosphonate and to a device, e.g. stent adapted for such local administration.
(FR)L'invention concerne une méthode permettant de traiter l'athérosclérose, notamment la calcification athérosclérotique/valvulaire et la rupture de plaque athérosclérotique/l'accident cérébral vasculaire, chez un patient requérant un traitement de ce type, par ex. un patient souffrant de calcification artérielle ou valvulaire. Cette méthode comprend l'administration au patient concerné, d'une quantité efficace de bisphosphonate, c.-à-d. d'acide zolédronique ou de sels ou d'hydrates dudit acide. L'invention concerne notamment l'administration locale de bisphosphonate, ainsi qu'un dispositif, c.-à-d. un tuteur intravasculaire adapté pour un tel mode d'administration locale.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MD, MK, MN, MX, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SE, SG, SK, SY, TJ, TM, TN, TR, TT, UA, US, UZ, VC, VN, YU, ZA, ZW.
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR).
Publication Language: English (EN)
Filing Language: English (EN)